Adaptive-outward and maladaptive-inward arterial remodeling measured by intravascular ultrasound in hyperhomocysteinemia and diabetes

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 11, Issue 1, 2006, Pages 65-76

  Reddy, Hanumanth K ^a   Koshy, Santhosh K G ^a   Wasson, Sanjeev ^a   Quan, Edwin E ^b   Pagni, Sebastian ^b   Roberts, Andrew M ^b   Joshua, Irving G ^b   Tyagi, Suresh C ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Atherosclerosis; Collagen; Elastin; Endothelial; Fibrous cap; Macrophage; Matrix metalloproteinase; Plaque rupture; Tissue inhibitor of matrix metalloproteinase

Indexed keywords

ALLOXAN; CIGLITAZONE; COLLAGEN; ELASTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART VENTRICLE HYPERTROPHY; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INTRAVASCULAR ULTRASOUND; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RESTENOSIS; SMOKING; STIMULUS RESPONSE; STRESS;

ANIMALS; COLLAGEN; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; ELASTIN; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MICE; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 33645724893     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840601100106     Document Type: Article

References (45)

1. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316:137-375, 1987
2. Cooper ME, Bonnet F, Oldfield M, et al. Mechanisms of diabetic vasculopathy: An overview. Am J Hypertens 14:47-86, 2001
3. Taylor AJ, Burke AP, Farb A, et al. Arterial remodeling in the left coronary system: The role of high-density lipoprotein cholesterol. J Am Coll Cardiol 34:76-67, 1999
4. Armstrong ML, Heistad DD, Marcus ML, et al. Structural and hemodynamic response of peripheral arteries of macaque monkeys to atherogenic diet. Arteriosclerosis 5:33-46, 1985
5. Maouad J, Fernandez F, Herbert JL, et al. Cigarette smoking during coronary angiography: Diffuse or focal narrowing (spasm) of the coronary arteries in 13 patients with angina at rest and normal coronary angiograms. Cathet Cardiovasc Diagn 12:366-375, 1986
6. Kool MJF, Hoeks APG, Struijker Boudier HAJ, et al. Short-and long-term effects of smoking on arterial wall properties in habitual smokers. J Am Coll Cardiol 22:1881-1886, 1993
7. Quillen JE, Rossen JD, Okarsson HJ, et al. Acute effect of cigarette smoking on the coronary circulation: Constriction of epicardial and resistance vessels. J Am Coll Cardiol 22:642-647, 1993
8. Weissman NJ, Sheris SJ, Chari R, et al. Intravascular ultrasonic analysis of plaque characteristics associated with coronary artery remodeling. Am J Cardiol 84:37-40, 1999
9. Jeremias A, Spies C, Herity NA, et al. Coronary artery compliance and adaptive vessel remodeling in patients with stable and unstable coronary artery disease. Heart 84:314-319, 2000
10. Shaw JA, Kingwell BA, Walton AS, et al. Determinants of coronary artery compliance in subjects with and without angiographic coronary artery disease. J Am Coll Cardiol 39:1637-1643, 2002
11. Nakatani S, Yamagishi M, Tamai J, et al. Assessment of coronary artery distensibility by intravascular ultrasound. Application of simultaneous measurements of luminal area and pressure. Circulation 91:2904-2910, 1995
12. Sudhir K, Mullen WL, Hausmann D, et al. Contribution of endothelium-derived nitric oxide to coronary arterial distensibility: An in vivo two-dimensional intravascular ultrasound study. Am Heart J 129:726-732, 1995
13. Rasheed Q, Hodgson JM. Application of intracoronary ultrasonography in the study of coronary artery pathophysiology. J Clin Ultrasound 21:569-578, 1993
14. Camp TM, Tyagi SC, Senior RM, et al. Gelatinase B (MMP-9) an apoptotic factor in diabetic transgenic mice, Diabetologia 46:1438-1446, 2003
15. Jeremias A, Spies C, Herity NA, et al. Coronary artery distensibility and compensatory vessel enlargement-a novel parameter influencing vascular remodeling? Basic Res Cardiol 96:506-512, 2001
16. Mujumdar VS, Aru GM, Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 82:491-500, 2001
17. Nakamura M, Nishikawa H, Mukai S, et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: An intravascular ultrasound study. J Am Coll Cardiol 37:63-69, 2001
18. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 15:1512-1531, 1995
19. Mintz GS, Kent KM, Richard AD, et al. Contribution of inadequate arterial remodeling to the development of focal coronary stenoses: An intravascular ultrasound study. Circulation 95:1791-1798, 1997
20. Maytin M, Leopold J, Loscalzo J. Oxidant stress in the vasculature. Cur Atherosclero Rep 1:156-164, 1999
21. Hunt MJ, Tyagi SC. Peroxisome proliferators compete and ameliorate homocysteine-mediated endocardial endothelial cells activation. Am J Physiol 283:C1073-C1079, 2002
22. Bierhaus A, Hofmann MA, Ziegler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. 1. The AGE concept. Cardiovasc Res 37:586-600, 1998
23. Feliciano L, Henning RJ. Coronary artery blood flow: Physiologic and pathophysiologic regulation. Clin Cardiol 22:775-786, 1999
24. De Meyer GR, Herman AG. Vascular endothelial dysfunction. Prog Cardiovasc Dis 39:325-342, 1997
25. Nakano H, Yamada K, Nishimura M, et al. Effect of hypercholesteremia on vascular endothelial function & albumin excretion rate in patients with diabetes, Japan Jour Nephrol 38:507-512, 1996
26. Tyagi SC, Meyer L, Schmaltz RA, et al. Proteinases and restenosis in human coronary artery: Extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 116:43-57, 1995
27. Vavuranakis M, Stefanadis C, Triandaphyllidi E, et al. Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal area and intracoronary pressure: Evidence of impaired reactivity to nitroglycerin. J Am Coll Cardiol 34:1075-1081, 1999
28. Mabuchi H, Michishita I, Sakai Y, et al. Coronary ectasia in a homozygous patient with familial hypercholesterolemia. Atherosclerosis 59:43-46, 1986
29. Genda A, Nakayama A, Shimizu M, et al. Coronary angiographic characteristics in Japanese patients with heterozygous familial hypercholesterolemia. Atherosclerosis 66:29-36, 1987
30. Sudhir K, Ports TA, Amidon TM, et al. Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia. Circulation 91:1375-1380, 1995
31. Kajinami K, Kasashima S, Oda Y, et al. Coronary ectasia in familial hypercholesterolemia: Histopathologic study regarding matrix metalloproteinases. Mod Pathol 12:1174-1180, 1999
32. Pini R, Cavallini MC, Bencini F, et al. Cardiac and vascular remodeling in older adults with borderline isolated systolic hypertension: The ICARe Dicomano Study. Hypertension 38:1372-1376, 2001
33. Hamasaki S, AlSuwaidi J, Higano ST, et al. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 35:1654-1660, 2000
34. Kaufmann P, Vassalli G, Lupi-Wagner S, et al. Coronary artery dimensions in primary and secondary left ventricular hypertrophy. J Am Coll Cardiol. 28:745-750, 1996
35. Dodge JT Jr, Brown BG, Bolson EL, et al. Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation 86:232-246, 1992
36. Mosseri M, Zolti E, Rozenman Y, et al. The diameter of the epicardial coronary arteries in patients with dilated cardiomyopathy. Int J Cardiol 62:133-141, 1997
37. Mela T, Meyer TE, Pape LA, et al. Coronary arterial dimension-to-left ventricular mass ratio in idiopathic dilated cardiomyopathy. Am J Cardiol 83:1277-1280, 1999
38. Inoue T, Sakai Y, Morooka S, et al. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J 125:93-98, 1993
39. Nitenberg A, Foult JM, Blanchet F, et al. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol 15:748-754, 1985
40. Chati Z, Bruntz JF, Ethevenot G, et al. Abnormal transoesophageal Doppler coronary flow reserve in patients with dilated cardiomyopathy: Relationship to exercise capacity. Clin Sci 94:485-492, 1998
41. Lababidi Z, Mehranpour M. Thrombotic occlusion of coronary aneurysms in Kawasaki disease: Sequential angiographic demonstration. Am Heart J 102:132-134, 1981
42. Matsuda H, Hashimoto N, Suzuki K, et al. Long-term follow-up of a patient with Kawasaki disease and coronary aneurysm associated with asymptomatic thrombosis: A case report. J Cardiol 46:113-118, 2005
43. Iemura M, Ishii M, Sugimura T, et al. Long term consequences of regressed coronary aneurysms after Kawasaki disease: Vascular wall morphology and function. Heart 83:307-311, 2000
44. Yamakawa R, Ishii M, Sugimura T, et al. Coronary endothelial dysfunction after Kawasaki disease: Evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 31:1074-1080, 1998
45. Pongratz G, Gansser R, Bachmann K, et al. Myocardial infarction in an adult resulting from coronary aneurysms previously documented in childhood after an acute episode of Kawasaki's disease. Eur Heart J 15:1002-1004, 1994